Contemporary management of ST-segment elevation myocardial infarction
Arun Karunakaran1, Wael Sumaya, Julian P Gunn
1Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom.
Hospital Practice (1995)
|March 13, 2012
Summary
ST-segment elevation myocardial infarction (STEMI) is a major cause of death. This review summarizes recent advances in managing STEMI, aiming to reduce its significant morbidity and mortality.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Coronary heart disease (CHD) is the primary global cause of mortality.
- In the US, CHD accounted for approximately 1 in 6 deaths in 2007.
- Acute coronary events often result from atherosclerotic plaque rupture, causing myocardial ischemia and infarction.
Purpose of the Study:
- To summarize key recent advances in the management of ST-segment elevation myocardial infarction (STEMI).
Main Methods:
- Literature review of recent advancements in STEMI management.
- Focus on clinical presentation, pathophysiology, and treatment options.
Main Results:
- ST-segment elevation myocardial infarction (STEMI) is characterized by complete coronary artery occlusion and high in-hospital mortality.
- Despite treatments like percutaneous coronary intervention, ischemic heart disease remains a significant cause of morbidity and mortality.
Conclusions:
- Ongoing research and clinical advancements are crucial for improving outcomes in STEMI patients.
- Effective management strategies continue to evolve to combat the high burden of ischemic heart disease.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...